Literature DB >> 26581782

Validation of fibromyalgia survey questionnaire and polysymptomatic distress scale in a Persian population.

Ali Bidari1, Banafsheh Ghavidel-Parsa2, Alireza Amir Maafi3, Ali Montazeri4, Babak Ghalehbaghi5, Amir Hassankhani3, Yasaman Aarabi3, Afrooz Haghdoost3.   

Abstract

The aim of this study was to assess validity of the fibromyalgia survey questionnaire (FSQ) and polysymptomatic distress scale (PSD) in an Iranian population. We also sought to classify the severity levels of fibromyalgia (FM) symptoms according to the PSD scale. Participants were divided into FM and non-FM chronic pain disorder groups according to expert physician diagnosis. Patients in both groups answered to Persian-translated version of FSQ, fibromyalgia impact questionnaire (FIQ) and Short-Form-12 (SF-12). Both 1990 ACR criteria and FSDC were assessed in participates of two groups. Internal consistency and construct validity were evaluated. There was good internal consistency measured by Cronbach's alpha (0.814 for FSQ). FSQ and its subscales correlated significantly with FIQ scores and SF-12 subscales, indicating acceptable construct validity. The concordance rates of FSQ with 1990 ACR criteria and expert diagnosis were 61.2 and 75.7, respectively (convergence validity). The mean score of PSD and its components in FM group were significantly more than in control groups (discriminative validity). Using lower PSD score cutoff (≥8.5) for the diagnosis of fibromyalgia appeared to be the most effective approach in our population. ROC analysis of the PSD scores revealed 8.5-11.5, 11.5-15 and more than 15, respectively, as a mild, moderate and severe FM. Persian version of FSQ was a valid instrument for application in survey research among Iranian patients with chronic pain disorders. The current study revealed that PSD could be used as a valid tool for assessment of symptoms intensity regardless of fibromyalgia diagnosis.

Entities:  

Keywords:  Fibromyalgia; Persian; Validity

Mesh:

Year:  2015        PMID: 26581782     DOI: 10.1007/s00296-015-3340-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

1.  New American College of Rheumatology criteria for fibromyalgia: a twenty-year journey.

Authors:  Frederick Wolfe
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

2.  Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Authors:  Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Winfried Häuser; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield
Journal:  J Rheumatol       Date:  2011-02-01       Impact factor: 4.666

3.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

4.  The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic.

Authors:  F Wolfe
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

5.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

6.  A questionnaire using the modified 2010 American College of Rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice.

Authors:  Robert Ferrari; Anthony S Russell
Journal:  J Rheumatol       Date:  2013-07-01       Impact factor: 4.666

7.  Minimal clinically important difference in the fibromyalgia impact questionnaire.

Authors:  Robert M Bennett; Andrew G Bushmakin; Joseph C Cappelleri; Gergana Zlateva; Alesia B Sadosky
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

8.  Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P).

Authors:  Ali Bidari; Morteza Hassanzadeh; Mohamad-Farzam Mohabat; Elham Talachian; Effat Merghati Khoei
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

9.  The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Pantelis Panopalis; Henri Ménard; Yoram Shir; Fred Wolfe
Journal:  BMC Musculoskelet Disord       Date:  2012-09-20       Impact factor: 2.362

10.  Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey.

Authors:  Winfried Häuser; Eva Jung; Brigitte Erbslöh-Möller; Mechthild Gesmann; Hedi Kühn-Becker; Franz Petermann; Jost Langhorst; Thomas Weiss; Andreas Winkelmann; Frederick Wolfe
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more
  7 in total

1.  No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Ashkan Rahimi; Faeze Gharibpoor; Mohammad-Javad Khosousi
Journal:  Clin Rheumatol       Date:  2021-08-22       Impact factor: 3.650

Review 2.  Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives.

Authors:  Carmen M Galvez-Sánchez; Gustavo A Reyes Del Paso
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

3.  Fibromyalgia diagnostic model derived from combination of American College of Rheumatology 1990 and 2011 criteria.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Asghar Hajiabbasi; Irandokht Shenavar; Babak Ghalehbaghi; Omid Sanaei
Journal:  Korean J Pain       Date:  2019-04-01

Review 4.  Reporting Survey Based Studies - a Primer for Authors.

Authors:  Prithvi Sanjeevkumar Gaur; Olena Zimba; Vikas Agarwal; Latika Gupta
Journal:  J Korean Med Sci       Date:  2020-11-23       Impact factor: 2.153

5.  Implication of the Nociplastic Features for Clinical Diagnosis of Fibromyalgia: Development of the Preliminary Nociplastic-Based Fibromyalgia Features (NFF) Tool.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Zahra Atrkarroushan; Mohammad-Javad Khosousi
Journal:  ACR Open Rheumatol       Date:  2021-12-22

6.  Comparison of the serum brain-derived neurotrophic factor (BDNF) between fibromyalgia and nociceptive pain groups; and effect of duloxetine on the BDNF level.

Authors:  Ali Bidari; Banafsheh Ghavidel-Parsa; Faeze Gharibpoor
Journal:  BMC Musculoskelet Disord       Date:  2022-05-02       Impact factor: 2.562

7.  Validity and reliability of the Persian version of illness invalidation inventory (3*I) among patients with non-inflammatory rheumatic painful disorders.

Authors:  Banafsheh Ghavidel-Parsa; Mohammad-Javad Khosousi; Sepehr Tohidi; Ali Bidari; Saman Soltani; Habib Zayeni; Ali Montazeri
Journal:  BMC Rheumatol       Date:  2022-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.